4/A

PRIMARY DOCUMENT

Company: Vistagen Therapeutics, Inc.
Filed: January 9, 2012
Period of Report: December 15, 2011
Accession Number: 0001222139-12-000002

View Document ↗ View on SEC.gov ↗